RK Damani’s Derive Investments buys 26.5 lakh shares of Fortis Healthcare

NEW DELHI: RK Damani’s Derive Investments on Monday bought 26.5 lakh shares of Fortis Healthcare.

The firm bought 26,58,843 shares of Fortis Healthcare at Rs 144.50 apiece in a bulk deal, NSE data showed.

Shares of Fortis Healthcare on Monday gained over 7 per cent to settle at Rs 147.60 apiece on NSE.

Earlier this month, Delhi High Court allowed Daiichi Sankyo to enforce an international arbitration award so that it could recover Rs 3,500 crore from Fortis Healthcare’s promoters Malvinder Singh and Shivinder Singh, marking a victory for the Japanese company. Days after the verdict, Singh brothers quit the Fortis board.

In the latest development, the government has ordered a Serious Fraud Investigation Office (SFIO) probe against Fortis Healthcare and Religare Enterprises, which are at the centre of a controversy involving accusations of misconduct against their promoters Malvinder and Shivinder Singh, said a TNN report.

However, in a clarification submitted to BSE on Monday, the company said it had not received any such communication from government authority.

  • Related Posts

    Medicines that cure Us are making Our Environment Sick

    Antimicrobial Resistance Campaigner makes a Fervent Appeal for Safe Disposal of Leftover Medicines New Delhi: We invariably worry about what might be the side effects of medicines on our body…

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    National Organ Transplant Games2026 set World Record in Talkatora Indoor Stadium New Delhi: The National Organ Transplant Games began on a high note in Talkatora Indoor Stadium on November 1,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick